New imaging dye to find tumor edges in stomach cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a new imaging dye that helps surgeons see exactly where the tumor ends during stomach cancer surgery. It aims to remove all cancer cells while sparing healthy tissue, which may lead to a more precise operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have stomach or gastroesophageal junction adenocarcinoma (a type of stomach cancer).
- You must be scheduled for surgery to remove the tumor completely (radical resection).
- You must be at least 18 years old.
- You must not have had chemotherapy or radiation therapy before the surgery.
- You must be willing and able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dye that helps surgeons see if early gastric cancer has spread to nearby lymph nodes. It might help guide the extent of surgery needed.
This trial tests whether an “ICG” dye and special camera can help surgeons see cancer more clearly during surgery for advanced stomach cancer. It may help improve how safely and accurately surgeons remove the tumor and nearby lymph nodes.
This trial tests a new way to remove stomach cancer using 3D-4K cameras and a special dye during laparoscopic (keyhole) surgery. It may help surgeons see the cancer better and remove it more precisely.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
This trial tests whether using a special dye (called indocyanine green) during a minimally invasive laparoscopic surgery can help doctors see lymph nodes and cancer more clearly in patients with upper stomach cancer. The goal is to improve the precision of the surgery and possibly lead to better outcomes.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.